Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

被引：0
|
作者：
K. H. Chan
R. L. O’Connell
D. R. Sullivan
L. S. Hoffmann
K. Rajamani
M. Whiting
M. W. Donoghoe
M. Vanhala
A. Hamer
B. Yu
R. Stocker
M. K. C. Ng
A. C. Keech
机构：
[1] Royal Prince Alfred Hospital,Department of Cardiology
[2] Sydney Medical School,National Health and Medical Research Council Clinical Trials Centre, Level 6, Medical Foundation Building, K25
[3] The Heart Research Institute,Department of Biochemistry
[4] University of Sydney,Center for Vascular Research, School of Medical Sciences (Pathology) and Bosch Institute
[5] Royal Prince Alfred Hospital,Department of Medical Biochemistry
[6] University of Sydney,Unit of Family Practice
[7] Flinders Medical Centre,Department of Cardiology
[8] Central Finland Central Hospital,Department of Molecular and Clinical Genetics
[9] Nelson Hospital,undefined
[10] Royal Prince Alfred Hospital,undefined
来源：
Diabetologia | 2013年 / 56卷
关键词：
Amputation; Bilirubin; Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study; Peripheral arterial disease; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：724 / 736
页数：12
相关论文
共 50 条
  • [41] Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study
    Ong, Kwok-Leung
    Wu, Liang
    Januszewski, Andrzej S.
    O'Connell, Rachel L.
    Xu, Aimin
    Rye, Kerry-Anne
    Ma, Ronald C. W.
    Li, Huating
    Jenkins, Alicia J.
    Jia, Weiping
    Keech, Anthony C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 169
  • [42] A STUDY ON SERUM TOTAL BILIRUBIN AND URIC ACID IN NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS
    Mishra, Mridula
    Tiwari, Dhananjay
    Khan, Mohammad Mustufa
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (11): : 5884 - 5889
  • [43] Fenofibrate reduces the 38% risk of amputation among patients with type 2 diabetes: new results of the FIELD study
    Madiou, J. P.
    METABOLISMES HORMONES DIABETES ET NUTRITION, 2008, 12 (06): : 204 - 204
  • [44] Long-term fenofibrate therapy and cardiovascular events in people with type 2 diabetes mellitus (the FIELD study: randomised controlled trial)
    不详
    KARDIOLOGIYA, 2006, 46 (01) : 70 - 72
  • [45] The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
    Cardiovascular Diabetology, 3
  • [46] Evaluation of plasma fibrinogen levels in type 2 diabetes mellitus
    Desai, K. N. Pannag
    Roopakala, M. S.
    Silvia, C. R. Wilma Delphine
    Kumar, K. M. Prasanna
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2012, 32 (04) : 209 - 213
  • [47] Evaluation of plasma fibrinogen levels in type 2 diabetes mellitus
    K. N. Pannag Desai
    M. S. Roopakala
    C. R. Wilma Delphine Silvia
    K. M. Prasanna Kumar
    International Journal of Diabetes in Developing Countries, 2012, 32 : 209 - 213
  • [48] The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
    Barter, P.
    Best, J.
    Colman, P.
    d'Emden, M.
    Davis, T.
    Drury, P.
    Ehnholm, C.
    Glasziou, P.
    Hunt, D.
    Keech, A.
    Kesaniemi, Y. A.
    Laakso, M.
    Scott, R.
    Simes, R. J.
    Sullivan, D.
    Taskinen, M-R
    Whiting, M.
    Ansquer, J-C
    Fraitag, B.
    Anderson, N.
    Hankey, G.
    Hunt, D.
    Lehto, S.
    Mann, S.
    Romo, M.
    Li, L. P.
    Hennekens, C.
    MacMahon, S.
    Pocock, S.
    Tonkin, A.
    Wilhelmsen, L.
    Forder, P.
    Akauola, H.
    Alford, F.
    Barter, P.
    Beinart, I.
    Best, J.
    Bohra, S.
    Boyages, S.
    Colman, P.
    Connor, H.
    Darnell, D.
    Davis, T.
    Davoren, P.
    Lepre, F.
    De Looze, F.
    d'Emden, M.
    Duffield, A.
    Fassett, R.
    Flack, J.
    CARDIOVASCULAR DIABETOLOGY, 2004, 3 (1)
  • [49] Plasma Lipid Profiling to Predict Cardiovascular Events in Type 2 Diabetes
    Alshehry, Zahir H.
    Wong, Gerard
    Mundra, Piyushkumar A.
    Barlow, Christopher K.
    Mellett, Natalie A.
    Zoungas, Sophia
    Hillis, Graham S.
    Chalmers, John
    Woodward, Mark
    Meikle, Peter J.
    CIRCULATION, 2014, 130
  • [50] Serum lactate levels are associated with serum alanine aminotransferase and total bilirubin levels in patients with type 2 diabetes mellitus: A cross-sectional study
    Ishitobi, Minori
    Hosaka, Toshio
    Morita, Naru
    Kondo, Ken
    Murashima, Toshitaka
    Kitahara, Atsuko
    Takahashi, Kazuto
    Sumitani, Yoshikazu
    Tanaka, Toshiaki
    Yokoyama, Toshihiko
    Kondo, Takuma
    Ishida, Hitoshi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 149 : 1 - 8
12345